History of Autoimmune Disease Concept: From Ancient Descriptions to Modern Definition

The concept of autoimmunity — immune attack on self — evolved over centuries from clinical observations to a defined immunologic principle.

Early Clinical Descriptions (Pre-Immunology)

• Ancient texts: Descriptions of rheumatoid arthritis (Ebers Papyrus 1500 BCE), lupus-like rashes (Hippocrates), Graves' disease (Persian manuscripts).
• Biblical reference: Naomi's "dim eyes" (Ruth 1:14) speculated as Sjögren's — highly speculative; no diagnostic basis.
• 1555 Paracelsus "tarantism": Psychogenic/dancing mania — not autoimmune.
• 18th–19th century: Heberden's nodes (RA), Bright's disease (lupus nephritis), Basedow/Graves (toxic goiter) — described clinically, etiology unknown.

Foundational Immunologic Concepts

• 1900 — Paul Ehrlich: "Horror autotoxicus" — proposed immune system normally avoids self-reactivity; believed autoimmunity impossible.
• 1904 — Donath-Landsteiner: Paroxysmal cold hemoglobinuria — first demonstration of autoantibody (anti-P) causing disease.
• 1940s — Coombs test: Detected autoantibodies on RBCs (autoimmune hemolytic anemia).
• 1956 — Ernest Witebsky: Coined "autoimmunity"; established Witebsky's postulates for proving autoimmune etiology:
  1. Autoantibody/autoreactive T cells present.
  2. Antigen identified.
  3. Induction in experimental animals.
  4. Transfer reproduces disease.
• 1957 — Burnet's Clonal Selection Theory: Forbidden clones (self-reactive) normally deleted; escape → autoimmunity.
• 1960s — Rose & Witebsky: Experimental autoimmune thyroiditis (rabbits) — fulfilled postulates.

Modern Classification and Expansion

• Organ-specific: T1DM, Hashimoto's, Graves', MS, myasthenia, Addison's.
• Systemic: SLE, RA, Sjögren's, scleroderma, vasculitides.
• Autoinflammatory (innate immunity dysregulation): FMF, CAPS, Still's — distinct from adaptive autoimmunity.

Current Understanding

Autoimmunity arises from genetic susceptibility (HLA, non-HLA) + environmental triggers (infections, microbiome, toxins, UV, hormones) + loss of tolerance (central/thymic, peripheral/Treg, anergy, ignorance).

Therapeutic Evolution

• Corticosteroids (1949) → broad immunosuppression.
• Conventional DMARDs (methotrexate, azathioprine).
• Biologics (anti-TNF, anti-IL-6, anti-CD20, CTLA4-Ig, JAK inhibitors) — targeted pathways.
• Emerging: CAR-T for autoimmunity, antigen-specific tolerance induction.

Key point: Autoimmunity was not "discovered" at one moment but emerged from accumulating clinical, serologic, and experimental evidence. The term was formalized in 1956; the concept continues to expand.